Information on valuation, funding, acquisitions, investors, and executives for Sebia. Use the PitchBook Platform to explore the full profile.

Oct 1, 2024 · National estimates for Sebia sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.

Mar 17, 2025 · Sebia's Annual Report & Profile shows critical firmographic facts: What is the company's size? (Annual sales and employees) Sebia's annual revenues are $100 - $500 …

Founded in 1967, Sebia is a Global specialty In Vitro Diagnostic leader for the screening and monitoring of various diseases, primarily in the areas of Oncology (Multiple Myeloma), …

May 11, 2014 · French diagnostics outfit Sebia is up for sale, and its current private equity owner hopes to fetch a cool $1.37 billion for it. Sebia has the distinction of having been bought and …

European private equity firm Cinven today announces that it has entered into exclusive negotiations with a consortium led by Montagu Private Equity and Astorg Partners for the sale …

2 days ago · Private equity firm CVC Capital Partners Plc is considering options for its majority stake in French diagnostics provider Sebia, according to people familiar with the matter.

Sebia is the global provider of In Vitro Diagnostics, specializing in clinical protein electrophoresis equipment and reagents. Our solutions for disease screening and monitoring: Oncology …

Mar 27, 2025 · Sebia - Developer of electrophoresis-based in vitro diagnostics products. Acquired by Astorg Partners. Raised funding over 5 rounds from 6 investors. Sebia has 613 competitors.

Purchase and sale of analytical equipment. Manufacture and distribution of biochemical devices and products, laboratory equipment and products for clinical biology